Preventative Health and Longevity Company, Viome Life Sciences, Closes $86.5M Oversubscribed Series C Funding Round
Healthcare IT Today
AUGUST 31, 2023
We invested in Viome because of its unique RNA technology and cutting-edge AI which when combined with its massive bank of biological data has the potential to prevent an epidemic of chronic diseases like mental health, metabolic health, cognitive health, and digestive health,” said Robbie Schwietzer, Partner at Khosla Ventures.
Let's personalize your content